Studies have shown that alterations in genes encoding pro-inflammatory cytokines (IL-1β, IL-6) and their high concentrations contribute greatly to the occurrence, intensity and severity of various symptoms in cancer patients(14,25). This evidence concerns the gene IL6 and cancer.